| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.1365-2796.2008.01945.X |
| P8608 | Fatcat ID | release_ylnh6qlmovckpgo25i454eekke |
| P698 | PubMed publication ID | 18410590 |
| P5875 | ResearchGate publication ID | 5441281 |
| P2093 | author name string | J Nilsson | |
| G K Hansson | |||
| P2860 | cites work | Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. | Q53591922 |
| Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. | Q53591929 | ||
| Natural regulatory T cells control the development of atherosclerosis in mice | Q58149268 | ||
| Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice | Q24623151 | ||
| Medium- and large-vessel vasculitis | Q28196695 | ||
| Marginal-zone B cells | Q28201000 | ||
| The B7 family revisited | Q28240070 | ||
| Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications | Q28253399 | ||
| Apolipoprotein-mediated pathways of lipid antigen presentation | Q28275773 | ||
| Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity | Q28344371 | ||
| MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction | Q28581447 | ||
| The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein | Q28647592 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| Toll-like receptors and innate immunity | Q29615458 | ||
| TLR4 links innate immunity and fatty acid-induced insulin resistance | Q29617577 | ||
| Atherosclerosis. the road ahead | Q29618972 | ||
| Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease | Q31135767 | ||
| Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences | Q31135771 | ||
| Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis | Q33207408 | ||
| Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100. | Q33242507 | ||
| Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions | Q33294845 | ||
| T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses | Q33819043 | ||
| Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins | Q33834184 | ||
| Low density lipoprotein undergoes oxidative modification in vivo | Q33838672 | ||
| Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis | Q33890402 | ||
| Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice | Q33905765 | ||
| Cell biology of antigen processing in vitro and in vivo | Q33985828 | ||
| Modulation of atherosclerosis in mice by Toll-like receptor 2 | Q34063165 | ||
| Dendritic cells and their involvement in atherosclerosis | Q34069113 | ||
| T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein | Q34390132 | ||
| Cytokines in atherosclerosis: pathogenic and regulatory pathways | Q34511711 | ||
| CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells | Q34709777 | ||
| Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis | Q34737721 | ||
| Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma | Q37358413 | ||
| IFN-gamma potentiates atherosclerosis in ApoE knock-out mice | Q37368296 | ||
| Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques | Q37416056 | ||
| Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis | Q37869622 | ||
| Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis | Q37878782 | ||
| Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. | Q39808657 | ||
| Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis | Q40137011 | ||
| Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. | Q42514406 | ||
| Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice | Q43738082 | ||
| Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis : clinical significance determined in a follow-up study | Q43846699 | ||
| Subendothelial retention of atherogenic lipoproteins in early atherosclerosis | Q44029239 | ||
| Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice | Q44149442 | ||
| Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. | Q44459170 | ||
| Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice | Q44545474 | ||
| Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways | Q44807760 | ||
| B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice | Q44851046 | ||
| Timing affects the efficacy of LDL immunization on atherosclerotic lesions in apo E (-/-) mice | Q45014924 | ||
| Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization | Q45107482 | ||
| Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis | Q45232086 | ||
| Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility | Q45306054 | ||
| Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. | Q46095021 | ||
| Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes | Q46133692 | ||
| Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis | Q46652738 | ||
| Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice | Q46804215 | ||
| Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice | Q46859383 | ||
| Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice | Q46874178 | ||
| Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I. | Q47442034 | ||
| Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis | Q47788311 | ||
| Demonstration of immunoglobulin in the neighbourhood of advanced atherosclerotic plaques. | Q52506913 | ||
| Requirement for CD154 in the progression of atherosclerosis. | Q52536870 | ||
| Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis. | Q52539711 | ||
| Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. | Q52578310 | ||
| Innate and acquired immunity in atherogenesis | Q34986341 | ||
| Pattern recognition receptors: doubling up for the innate immune response | Q35036522 | ||
| Antigen-induced regulatory T cells in autoimmunity | Q35092544 | ||
| Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges | Q35134733 | ||
| Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation | Q35159020 | ||
| Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice | Q35160907 | ||
| Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype | Q35161070 | ||
| Oxidized phospholipids as modulators of inflammation in atherosclerosis | Q35539436 | ||
| Autoimmune and inflammatory mechanisms in atherosclerosis | Q35698466 | ||
| The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice | Q35792034 | ||
| Endogenous ligands of Toll-like receptors | Q35792678 | ||
| Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model | Q35824235 | ||
| Inferences, questions and possibilities in Toll-like receptor signalling | Q35829752 | ||
| Immune therapy for autoimmune diseases | Q35833158 | ||
| Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies | Q35888472 | ||
| The interface between innate and adaptive immunity | Q35904384 | ||
| Regulatory T cells: friend or foe in immunity to infection? | Q35934156 | ||
| Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors | Q35952837 | ||
| Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells | Q35956837 | ||
| Immunomodulation with human recombinant autoantigens | Q36254069 | ||
| How Toll-like receptors signal: what we know and what we don't know | Q36339101 | ||
| CD1d-dependent activation of NKT cells aggravates atherosclerosis. | Q36399122 | ||
| Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease | Q36399434 | ||
| Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory | Q36399652 | ||
| DNA damage and repair in atherosclerosis | Q36437572 | ||
| The immune response in atherosclerosis: a double-edged sword | Q36508676 | ||
| Phagocytosis of apoptotic cells and immune regulation | Q36511373 | ||
| Autoimmunity versus tolerance: can dying cells tip the balance? | Q36618394 | ||
| Regulatory T-cell immunity in atherosclerosis | Q36812076 | ||
| IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis | Q36849075 | ||
| Structure and function: heat shock proteins and adaptive immunity. | Q36901412 | ||
| Innate immunity, macrophage activation, and atherosclerosis | Q36938635 | ||
| Recent advances in antigen processing and presentation | Q36945533 | ||
| Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E | Q36986664 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 464-478 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | Journal of Internal Medicine | Q6295387 |
| P1476 | title | Autoimmunity in atherosclerosis: a protective response losing control? | |
| P478 | volume | 263 |
| Q37351550 | Actin is a target of T-cell reactivity in patients with advanced carotid atherosclerotic plaques |
| Q43235071 | Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere vascular study |
| Q38242815 | Adventitial inflammation and its interaction with intimal atherosclerotic lesions |
| Q26860162 | Anti-inflammatory therapy in chronic disease: challenges and opportunities |
| Q45935461 | Association between CD8+ T-cell subsets and cardiovascular disease. |
| Q37207913 | Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes |
| Q59335211 | Associations between circulating IgG antibodies to Apolipoprotein B-derived peptide antigens and acute coronary syndrome in a Chinese Han population |
| Q33761718 | CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ mice |
| Q35175305 | Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women |
| Q37375647 | Decreased CD127 expression on CD4+ T-cells and elevated frequencies of CD4+CD25+CD127- T-cells in children with long-lasting type 1 diabetes |
| Q49072554 | Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus. |
| Q89552373 | Dicarbonyl Stress and S-Glutathionylation in Cerebrovascular Diseases: A Focus on Cerebral Cavernous Malformations |
| Q97067098 | Differential Role for Activating FcγRIII in Neointima Formation After Arterial Injury and Diet-Induced Chronic Atherosclerosis in Apolipoprotein E-Deficient Mice |
| Q38938473 | Differential pro-inflammatory responses of TNF-α receptors (TNFR1 and TNFR2) on LOX-1 signalling |
| Q43243047 | Early increase in autoantibodies against human oxidized low-density lipoprotein in hypertensive patients after blood pressure control |
| Q37582576 | Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosus. |
| Q47112802 | Endothelial dysfunction assessment by flow-mediated dilation in a high-altitude population |
| Q38107072 | Free radicals and endothelial dysfunction: potential positive effects of TNF-α inhibitors. |
| Q34785574 | Gene Deficiency in Activating Fcγ Receptors Influences the Macrophage Phenotypic Balance and Reduces Atherosclerosis in Mice. |
| Q33930928 | High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes |
| Q46458340 | Immune responses elicited by apoB-100-derived peptides in mice. |
| Q36411136 | Immunoglobulins against tyrosine-nitrated epitopes in coronary artery disease |
| Q35174901 | Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice |
| Q33805176 | Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics |
| Q34440352 | Interleukin-17-dependent autoimmunity to collagen type V in atherosclerosis |
| Q64097359 | Keratin 8 is a potential self-antigen in the coronary artery disease immunopeptidome: A translational approach |
| Q41890791 | Leukocyte Bim deficiency does not impact atherogenesis in ldlr -/- mice, despite a pronounced induction of autoimmune inflammation |
| Q34505861 | Matrix metalloproteinases (MMP-2,9) and their tissue inhibitors (TIMP-1,2) as novel markers of stress response and atherogenesis in children with chronic kidney disease (CKD) on conservative treatment |
| Q36246980 | Mitochondrial mutations are associated with atherosclerotic lesions in the human aorta |
| Q27335174 | Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice |
| Q49188878 | Mutation Analysis of the Mitochondrial tRNA Genes in Iranian Coronary Atherosclerosis Patients |
| Q54943937 | Oxidative Stress Induces HSP90 Upregulation on the Surface of Primary Human Endothelial Cells: Role of the Antioxidant 7,8-Dihydroxy-4-methylcoumarin in Preventing HSP90 Exposure to the Immune System. |
| Q42791983 | Oxidative stress in cardiovascular inflammation: its involvement in autoimmune responses |
| Q33879138 | Oxidized LDL: diversity, patterns of recognition, and pathophysiology |
| Q35998510 | Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention |
| Q37328097 | Pentraxins, anti-pentraxin antibodies, and atherosclerosis |
| Q48194522 | Polymorphism in the chemokine receptor 7 gene (CCR7) is associated with previous myocardial infarction in patients undergoing elective coronary angiography |
| Q46546564 | Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011. |
| Q26778507 | Roles of antibody against oxygenized low density lipoprotein in atherosclerosis: recent advances |
| Q58914607 | T lymphocyte autoreactivity in inflammatory mechanisms regulating atherosclerosis |
| Q34221791 | TAP1-deficiency does not alter atherosclerosis development in Apoe-/- mice |
| Q37925018 | Targeting inflammation in cardiovascular diseases. still a neglected field? |
| Q38406177 | Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis |
| Q28277713 | The Ratio of Regulatory (FOXP3+) to Total (CD3+) T Cells Determined by Epigenetic Cell Counting and Cardiovascular Disease Risk: A Prospective Case-cohort Study in Non-diabetics |
| Q37560012 | The Role of Immunogenicity in Cardiovascular Disease |
| Q46485465 | The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice. |
| Q33821359 | The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice |
| Q90862800 | The proatherosclerotic function of indoleamine 2, 3-dioxygenase 1 in the developmental stage of atherosclerosis |
| Q37421814 | Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis |
Search more.